| Income Statement |
| Operating Expenses | 10.33M |
|
| Research and Development Expense | 5.91M |
| Selling, General and Administrative Expense | 4.43M |
| Operating Income | -10.33M |
| Net Income | -10.19M |
| Net Income Common Stock | -10.19M |
| Net Income Common Stock (USD) | -10.19M |
| Consolidated Income | -10.19M |
| Earnings per Basic Share | -0.32 |
| Earnings per Basic Share (USD) | -0.32 |
| Earnings per Diluted Share | -0.32 |
| Earning Before Interest & Taxes (EBIT) | -10.19M |
| Earning Before Interest & Taxes (USD) | -10.19M |
| Weighted Average Shares | 32.15M |
| Weighted Average Shares Diluted | 32.15M |
| Balance Sheet |
| Cash and Equivalents | 17.72M |
| Cash and Equivalents (USD) | 17.72M |
| Current Assets | 18.21M |
| Property, Plant & Equipment Net | 19.72M |
| Total Assets | 38.98M |
| Debt Current | 1.10M |
| Total Debt | 2.31M |
| Current Liabilities | 8.11M |
| Debt Non-Current | 1.21M |
| Total Liabilities | 9.34M |
| Accumulated Retained Earnings (Deficit) | -331.51M |
| Shareholders Equity | 29.64M |
| Shareholders Equity (USD) | 29.64M |
| Assets Non-Current | 20.77M |
| Total Debt (USD) | 2.31M |
| Deferred Revenue | 4.08M |
| Liabilities Non-Current | 1.23M |
| Trade and Non-Trade Payables | 620.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 187.00K |
| Net Cash Flow from Financing | 16.04M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 8.11M |
| Capital Expenditure | -39.00K |
| Issuance (Purchase) of Equity Shares | 16.04M |
| Net Cash Flow from Investing | -39.00K |
| Net Cash Flow from Operations | -7.89M |
| Share Based Compensation | 3.36M |